Intraepidermal Injections of Autologous Epidermal Cell Suspension: A New Promising Approach to Dermatological Disorders. Preliminary Study

    January 2017
    Fabio Rinaldi
    Image of study
    TLDR Injecting a person's own skin cells back into their skin is a promising, safe, and affordable treatment for skin disorders.
    The 2017 study "Intraepidermal Injections of Autologous Epidermal Cell Suspension: A new promising approach to Dermatological Disorders. Preliminary Study" investigated the potential of autologous epidermal cell suspension as a treatment for skin disorders, including non-scarring and scarring alopecia. The process involved injecting a patient's own epidermal cells, cultured for 7 days, back into their skin. The study, which involved 10 healthy volunteers, found a significant number of these cells remained viable after 7 days in culture. The procedure was deemed simple, fast, safe, and relatively inexpensive, with limited side effects. However, the researchers acknowledged the need for further studies to validate their findings in a larger group and through controlled and randomized clinical trials.
    Discuss this study in the Community →

    Cited in this study

    2 / 2 results